The Globe and Mail reports in its Tuesday, Feb. 24, edition that after a call with chief financial officer Mark Thompson following Nutrien's fourth quarter 2025 earnings release, RBC Capital Markets analyst Andrew Wong raised his share target to $80 from $75 (all figures U.S.). The Globe's David Leeder writes in the Eye On Equities column that Mr. Wong has reaffirmed his "outperform" recommendation for Nutrien. Analysts on average target the shares at $70.62. Mr. Wong says in a note: "We expect continued operational improvement driving steady organic retail growth, improved costs and cash conversion, and consistent growth in FCF/sh. We see further upside in shares with an attractive upside/downside profile and strong defensive commodity exposure." The Globe reported on July 16, 2024, Oct. 3, 2024, and May 13, 2025, that Mr. Wong was sticking with his "outperform" recommendation for Nutrien. The shares could then be had for $50.91, $49.94 and $58.06.